Circulating Biomarkers Market Is Set to Garner Staggering Revenues by 2020
Tumor cells when dying, release small pieces of their DNA into the bloodstream and these strands are known as cell-free circulating biomarkers. These biomarkers are becoming the part and parcel of healthcare management owing to their application in monitoring progression of a disease, performing a biopsy, and deciding a treatment regimen. They are used for therapeutics and diagnosis of broad array of specialties such as cardiovascular, immunology, neurology, cancer, and metabolic diseases.
View full press release